Literature DB >> 7790140

Dermatofibrosarcoma protuberans.

C K Koh1, C B Ko, H P Bury, E H Wyatt.   

Abstract

BACKGROUND: Dermatofibrosarcoma protuberans (DFSP) is an uncommon malignant tumor of the skin, the diagnosis of which can be difficult not only clinically but also histologically. The tumor has a low metastatic potential, but tends to recur locally if removal is incomplete.
METHODS: We reviewed the clinical and histologic features of 19 cases of DFSP, seen at the Department of Dermatology (14 cases) and Department of Surgery (5 cases) at the Hull Royal Infirmary between 1975 and 1992.
RESULTS: There were only 19 cases of DFSP diagnosed from a population of 500,000 over a period of 17 years. None of the cases were diagnosed clinically prior to histologic diagnosis. The highest incidence was in the 4th decade of age. The most frequent site was on the head and neck. None of the lesions metastasized but there were a total of eight incidents of local recurrence in five patients. Histologically all the cases showed presence of storiform-pattern spindle-shaped cells and new collagen formation.
CONCLUSIONS: Dermatofibrosarcoma protuberans is a soft tissue tumor that is often not recognized clinically due to its rarity and variable appearance. Local recurrence is frequent. A wide surgical excision is the treatment of choice.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7790140     DOI: 10.1111/j.1365-4362.1995.tb01591.x

Source DB:  PubMed          Journal:  Int J Dermatol        ISSN: 0011-9059            Impact factor:   2.736


  9 in total

1.  Dermatofibrosarcoma protuberans (DFSP): predictors of recurrence and the use of systemic therapy.

Authors:  Ryan C Fields; Meera Hameed; Li-Xuan Qin; Nicole Moraco; Xiaoyu Jia; Robert G Maki; Samuel Singer; Murray F Brennan
Journal:  Ann Surg Oncol       Date:  2010-09-16       Impact factor: 5.344

2.  Imatinib mesylate in advanced dermatofibrosarcoma protuberans: pooled analysis of two phase II clinical trials.

Authors:  Piotr Rutkowski; Martine Van Glabbeke; Cathryn J Rankin; Wlodzimierz Ruka; Brian P Rubin; Maria Debiec-Rychter; Alexander Lazar; Hans Gelderblom; Raf Sciot; Dolores Lopez-Terrada; Peter Hohenberger; Allan T van Oosterom; Scott M Schuetze
Journal:  J Clin Oncol       Date:  2010-03-01       Impact factor: 44.544

3.  Dermatofibrosarcoma protuberans: A case report of a rare, bulky tumor that was managed with surgical therapy.

Authors:  Ahmet Yılmaz; Erol Cenesizoglu; Ertuğrul Eğilmez; Safa Onel; Mehdi Muştu; Ahmet Cennet
Journal:  Int J Shoulder Surg       Date:  2009-01

4.  Operative management of dermatofibrosarcoma protuberans of the breast.

Authors:  Melissa H Kinney; Sally M Knox
Journal:  Proc (Bayl Univ Med Cent)       Date:  2016-07

Review 5.  Current treatment options in dermatofibrosarcoma protuberans.

Authors:  Doreen Lemm; L-O Mügge; T Mentzel; K Höffken
Journal:  J Cancer Res Clin Oncol       Date:  2009-02-10       Impact factor: 4.553

6.  Advances in molecular characterization and targeted therapy in dermatofibrosarcoma protuberans.

Authors:  Piotr Rutkowski; Agnieszka Wozniak; Tomasz Switaj
Journal:  Sarcoma       Date:  2011-03-30

Review 7.  Indication guidelines for Mohs micrographic surgery in skin tumors.

Authors:  Selma Schuartz Cernea; Gabriel Gontijo; Eugenio Raul de Almeida Pimentel; Roberto Gomes Tarlé; Glaysson Tassara; Juliana Areas de Souza Lima Beltrame Ferreira; Victor Miguel Coutinho Fernandes; Wanderley Marques Bernardo
Journal:  An Bras Dermatol       Date:  2016 Sep-Oct       Impact factor: 1.896

8.  Recurrent Dermatofibrosarcoma Protuberans of the Head and Neck: a Case Series.

Authors:  Suresh Mani; Rajeev Kumar; Aanchal Kakkar; Adarsh Barwad; Kondamudi Dheeraj; Prem Sagar; Rakesh Kumar
Journal:  Indian J Surg Oncol       Date:  2022-09-01

9.  Fibrosarcomatous changes and expression of CD34+ and apolipoprotein-D in dermatofibrosarcoma protuberans.

Authors:  Emanuela Palmerini; Marco Gambarotti; Eric L Staals; Licciana Zanella; Gabriela Sieberova; Alessandra Longhi; Marilena Cesari; Stefano Bonarelli; Piero Picci; Pietro Ruggieri; Marco Alberghini; Stefano Ferrari
Journal:  Clin Sarcoma Res       Date:  2012-01-27
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.